Pharmacologic implications of neurobiological models of schizophrenia.
作者： Donald C. Goff
DOI: 10.1080/10673220500433262
关键词:
摘要: The dopamine model of schizophrenia has been supplanted by several additional models in order to account for genetic findings, risk factors, course illness, and the diversity symptom domains. increasing number complexity potential this heterogeneous disorder offer new targets pharmacologic treatment that differ their appropriate time points intervention effects on illness. This article reviews relevant neurodevelopmental, biochemical, neurodegenerative with respect opportunities.
wkhealth.com参考文章(80)
Laruelle M, Imaging dopamine transmission in schizophrenia. A review and meta-analysis. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine. ,vol. 42, pp. 211- 221 ,(1998)
S Kapur, P Seeman, Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. Journal of Psychiatry & Neuroscience. ,vol. 25, pp. 161- 166 ,(2000)
Ou Bai, Jennifer Chlan-Fourney, Rudy Bowen, David Keegan, Xin-Min Li, Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs Journal of Neuroscience Research. ,vol. 71, pp. 127- 131 ,(2003) , 10.1002/JNR.10440
E. F. Walker, T. Savoie, D. Davis, Neuromotor Precursors of Schizophrenia Schizophrenia Bulletin. ,vol. 20, pp. 441- 451 ,(1994) , 10.1093/SCHBUL/20.3.441
J. L. Waddington, Tardive dyskinesia in schizophrenia and other disorders: Associations with ageing, cognitive dysfunction and structural brain pathology in relation to neuroleptic exposure Human Psychopharmacology-clinical and Experimental. ,vol. 2, pp. 11- 22 ,(1987) , 10.1002/HUP.470020104
TORGNY H. SVENSSON, JAN M. MATHÉ, JONAS L. ANDERSSON, BMGEORGE G. NOMIKOS, BENGT E. HILDEBRAND, MONICA MARCUS, Mode of Action of Atypical Neuroleptics in Relation to the Phencyclidine Model of Schizophrenia: Role of 5-HT2 Receptor and α1-Adrenoreceptor Antagonism Journal of Clinical Psychopharmacology. ,vol. 15, ,(1995) , 10.1097/00004714-199502001-00003
Guochuan Tsai, Pinchen Yang, Li-Chen Chung, Nicholas Lange, Joseph T. Coyle, D-serine added to antipsychotics for the treatment of schizophrenia Biological Psychiatry. ,vol. 44, pp. 1081- 1089 ,(1998) , 10.1016/S0006-3223(98)00279-0
PatriciaS. Goldman-Rakic, StacyA. Castner, TorgnyH. Svensson, LarryJ. Siever, GrahamV. Williams, Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction Psychopharmacology. ,vol. 174, pp. 3- 16 ,(2004) , 10.1007/S00213-004-1793-Y
Vinay Parikh, Mohammad M. Khan, Sahebarao P. Mahadik, Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol. Neuroscience Letters. ,vol. 356, pp. 135- 139 ,(2004) , 10.1016/J.NEULET.2003.10.079
Schahram Akbarian, Angel Viñuela, James J Kim, Steven G Potkin, William E Bunney, Edward G Jones, Distorted Distribution of Nicotinamide-Adenine Dinucleotide Phosphate—Diaphorase Neurons in Temporal Lobe of Schizophrenics Implies Anomalous Cortical Development Archives of General Psychiatry. ,vol. 50, pp. 178- 187 ,(1993) , 10.1001/ARCHPSYC.1993.01820150016002